Lexicon Pharmaceuticals Inc
LXRX
$1.65+3.13%
End of day · as of Oct 16, 2026, 2:01 AM ET
Mkt cap
$327.22M
EV/Sales
6.97
P/E ratio
N/A
FY2025 Revenue
$49.80M
EPS (TTM)
$-0.16
Gross Margin (FY2025)
99.45%
Profit Margin (FY2025)
-101.08%
Beta
1.01
Div yield
N/A
Sector
Healthcare
Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
Latest reported LXRX revenue for 2025-12-31 was $49.8M. Net income was -$50.3M. Revenue was up 60.2% from 2024-12-31 to 2025-12-31. LXRX currently screens at market cap $327.2M.
Use this LXRX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full LXRX income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company in the Healthcare sector.
Latest cached Lexicon Pharmaceuticals Inc (LXRX) revenue for Dec 31, 2025 was $49.8M. Net income was -$50.3M. Statements: https://lician.com/financials/lxrx
Lexicon Pharmaceuticals Inc (LXRX) market capitalization is $327.2M on the latest cached snapshot.
Lexicon Pharmaceuticals Inc (LXRX) cached previous close $1.60; day range $1.63 – $1.65; volume 1,282,546. Session quote: https://lician.com/quote/lxrx
Lexicon Pharmaceuticals Inc (LXRX) latest cached earnings event is "LXRX earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached LXRX filing is 8-K · Aug 6, 2026. Filings: https://lician.com/sec/lxrx